Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

Published loading...Updated

Sweden Lost Its Novo Nordisk in 1999: Now Rumors Are Ripping up the Past

Summary by borsen.dk
A gigantic merger may be on the way, if the Financial Times' anonymous sources are to be believed, between the Swedish-British pharmaceutical giant Astrazeneca and its American counterpart Bristol Myers Squibb.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

A gigantic merger may be on the way, if the Financial Times' anonymous sources are to be believed, between the Swedish-British pharmaceutical giant Astrazeneca and its American counterpart Bristol Myers Squibb.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

borsen.dk broke the news on Monday, August 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal